ARTICLE | Clinical News
Sutent sunitinib regulatory update
May 16, 2011 7:00 AM UTC
The Scottish Medicines Consortium recommended the use of Pfizer's Sutent sunitinib on the National Health Service (NHS) in Scotland to treat unresectable or metastatic, well-differentiated pancreatic ...